Catherine C. Turkel, President at Novus Therapeutics, Inc. (NVUS), bought 67,360 shares at $4.56 ($322K) on 2018-09-11, disclosed to the SEC on 2018-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.56 | 17,048 | $78K | 24.1% |
| 2 | $4.56 | 17,048 | $78K | 24.1% |
| 3 | $5.02 | 16,632 | $83K | 25.9% |
| 4 | $5.02 | 16,632 | $83K | 25.9% |
| Total | $4.79 avg | 67,360 | $322K | 100% |
| Filing → |
| NVUS | SELL | 2019-05-22 | $19K | — | Filing → |
| NVUS | BUY | 2018-09-07 | $3K | — | Filing → |
| NVUS | BUY | 2017-05-11 | $222K | — | Filing → |